Taken together, these mechanistic data delineate a pathway wherein AHCY recruits PRMT3 to methylate LDHA at R106, enhancing its stability and glycolytic function to promote ESCC growth. The gene discussed is PRMT3; the disease is esophageal squamous cell carcinoma.